{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:29:19Z","timestamp":1777894159403,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012218","name":"Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy","doi-asserted-by":"publisher","award":["25KF28"],"award-info":[{"award-number":["25KF28"]}],"id":[{"id":"10.13039\/501100012218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012218","name":"Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy","doi-asserted-by":"publisher","award":["XZSYSKF2021028"],"award-info":[{"award-number":["XZSYSKF2021028"]}],"id":[{"id":"10.13039\/501100012218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116416","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:30:50Z","timestamp":1771648250000},"page":"116416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exenatide through PPAR\u03b4 improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosis"],"prefix":"10.1016","volume":"175","author":[{"given":"Xizhi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116416_bb0005","article-title":"GLP-1R agonists: recent advances, current gaps, and future challenges","author":"Saran","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.intimp.2026.116416_bb0010","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.2147\/DDDT.S559919","article-title":"The clinical application of GLP-1RAs and GLP-1\/GIP dual receptor agonists based on pharmacological mechanisms: A review","volume":"19","author":"Liu","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.116416_bb0015","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.28827","article-title":"Exenatide improves both hepatic and adipose tissue insulin resistance: a dynamic positron emission tomography study","volume":"64","author":"Gastaldelli","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.116416_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1012904","article-title":"Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.intimp.2026.116416_bb0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1098612X16660441","article-title":"New approaches to feline diabetes mellitus: glucagon-like peptide-1 analogs","volume":"18","author":"Gilor","year":"2016","journal-title":"J. Feline Med. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2026.116416_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tem.2016.03.017","article-title":"Perspectives in GLP-1 research: new targets, New Receptors","volume":"27","author":"Cantini","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.116416_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.949990","article-title":"Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus","volume":"13","author":"Song","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab. J."},{"issue":"2","key":"10.1016\/j.intimp.2026.116416_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"131","author":"Taylor","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116416_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116416_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084467","article-title":"PPARs as key transcription regulators at the crossroads of metabolism and inflammation","volume":"25","author":"Vazquez-Carrera","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2026.116416_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152432","article-title":"Peroxisome proliferator-activated receptors and the hallmarks of cancer","volume":"11","author":"Wagner","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116416_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216937","article-title":"Activation of PPARdelta in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury","volume":"592","author":"Liang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116416_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117303","article-title":"PPARbeta\/delta attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2026.116416_bb0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2337\/db07-1318","article-title":"Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men","volume":"57","author":"Riserus","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.116416_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.136740","article-title":"NLRP3 inflammasome mediates pyroptosis of alveolar macrophages to induce radiation lung injury","volume":"484","author":"Zhang","year":"2025","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.intimp.2026.116416_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112771","article-title":"Ubiquitinated gasdermin D mediates arsenic-induced pyroptosis and hepatic insulin resistance in rat liver","volume":"160","author":"Zhu","year":"2022","journal-title":"Food Chem. Toxicol. : Int. J. Published Br. Ind. Biol. Res. Assoc."},{"issue":"19","key":"10.1016\/j.intimp.2026.116416_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911638","article-title":"Pyroptosis and insulin resistance in metabolic organs","volume":"23","author":"Wei","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116416_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbr.2018.06.005","article-title":"PPAR\u00df\/\u03b4 agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson\u2019s disease","volume":"356","author":"Chen","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"21","key":"10.1016\/j.intimp.2026.116416_bb0100","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1111\/jcmm.15698","article-title":"GW0742 activates miR-17-5p and inhibits TXNIP\/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells","volume":"24","author":"Gamdzyk","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116416_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108932","article-title":"The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"39","author":"Ren","year":"2025","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.intimp.2026.116416_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1098391","article-title":"Impact of GLP-1 receptor agonist versus omega-3 fatty acids supplement on obesity-induced alterations of mitochondrial respiration","volume":"14","author":"Jansen","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2026.116416_bb0115","article-title":"Exenatide attenuates non-alcoholic steatohepatitis by inhibiting the Pyroptosis signaling pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2026.116416_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2014.01.071","article-title":"Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice","volume":"729","author":"Novelli","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0668-1","article-title":"Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats","volume":"8","author":"Sun","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2026.116416_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116416_bb0135","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00125-011-2401-4","article-title":"The peroxisome proliferator-activated receptor (PPAR) \u03b2\/\u03b4 agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells","volume":"55","author":"Serrano-Marco","year":"2012","journal-title":"Diabetologia"},{"issue":"48","key":"10.1016\/j.intimp.2026.116416_bb0140","doi-asserted-by":"crossref","first-page":"14544","DOI":"10.1021\/acs.jafc.1c05400","article-title":"Estrogen receptor \u03b1 regulates metabolic-associated fatty liver disease by targeting NLRP3-GSDMD axis-mediated hepatocyte pyroptosis","volume":"69","author":"Gao","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.116416_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.116101","article-title":"Salidroside alleviates ethanol exposure-exacerbated hepatic insulin resistance in diabetic mice","volume":"171","author":"Xiang","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2026.116416_bb0155","first-page":"S10","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","volume":"59","author":"Bansal","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2026.116416_bb0160","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.cmet.2021.07.010","article-title":"Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and hepatic steatosis","volume":"33","author":"Jiang","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hep.32501","article-title":"Src homology 3 domain binding kinase 1 protects against hepatic steatosis and insulin resistance through the Nur77-FGF21 pathway","volume":"77","author":"Ahuja","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59773-4","article-title":"GLP-1R\/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic \u03b2-cell function in obese male mice","volume":"16","author":"Laker","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116416_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113937","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice","volume":"147","author":"Hu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116416_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104984","article-title":"Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies","volume":"159","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in Ob\/Ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00018-025-05844-0","article-title":"GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic \u03b2-cells against lipotoxicity via PPAR\u03b4\/UCP2 pathway","volume":"82","author":"Liu","year":"2025","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.intimp.2026.116416_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116416_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tem.2016.02.008","article-title":"Unraveling the effects of PPAR\u03b2\/\u03b4 on insulin resistance and cardiovascular disease","volume":"27","author":"V\u00e1zquez-Carrera","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2026.116416_bb0205","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jhep.2009.01.021","article-title":"PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair","volume":"50","author":"Pang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2026.116416_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155934","article-title":"Estradiol contributes to sex differences in resilience to sepsis-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPAR\u03b4\/NLRP3 signaling","volume":"156","author":"Adu-Amankwaah","year":"2024","journal-title":"Metab. Clin. Exp."},{"issue":"16","key":"10.1016\/j.intimp.2026.116416_bb0215","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/bph.16074","article-title":"Peroxisome proliferator-activated receptor \u03b4 improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching","volume":"180","author":"Lien","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116416_bb0220","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","article-title":"GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.116416_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114177","article-title":"Novel bioactive peptides alleviate Western diet-induced MAFLD in C57BL\/6J mice by inhibiting NLRP3 inflammasome activation and pyroptosis via TLR4\/NF-\u03baB and Keap1\/Nrf2\/HO-1 signaling pathways","volume":"148","author":"Wayal","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116416_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8905917","article-title":"Exendin-4 protects against hyperglycemia-induced cardiomyocyte pyroptosis via the AMPK-TXNIP pathway","volume":"2019","author":"Wei","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116416_bb0235","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.apsb.2020.11.006","article-title":"S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling","volume":"11","author":"Luo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"Pt 3","key":"10.1016\/j.intimp.2026.116416_bb0240","article-title":"Fibroblast growth factor 1 (FGF1) improves glucose homeostasis, modulates gut microbial composition, and reduces inflammatory responses in rainbow trout (Oncorhynchus mykiss) fed a high-fat diet","volume":"281","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900728","article-title":"Vitamin D deficiency induces insulin resistance and re-supplementation attenuates hepatic glucose output via the PI3K-AKT-FOXO1 mediated pathway","volume":"64","author":"Mutt","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"issue":"19","key":"10.1016\/j.intimp.2026.116416_bb0250","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/bph.16421","article-title":"Role of LRP5\/6\/GSK-3\u03b2\/\u03b2-catenin in the differences in exenatide- and insulin-promoted T2D osteogenesis and osteomodulation","volume":"181","author":"Chen","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-02800-8","article-title":"Exendin-4 and eldecalcitol synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells through M2 macrophages polarization via PI3K\/AKT pathway","volume":"13","author":"Lu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"26","key":"10.1016\/j.intimp.2026.116416_bb0260","doi-asserted-by":"crossref","first-page":"15924","DOI":"10.1073\/pnas.0306981100","article-title":"Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome","volume":"100","author":"Tanaka","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2026.116416_bb0265","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3892\/ijmm.2015.2270","article-title":"Treatment with PPAR\u03b4 agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model","volume":"36","author":"Li","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116416_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4779199","article-title":"PPAR\u03b2\/\u03b4 agonism with GW501516 increases myotube PGC-1\u03b1 content and reduces BCAA media content independent of changes in BCAA catabolic enzyme expression","volume":"2023","author":"Rivera","year":"2023","journal-title":"PPAR Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0275","article-title":"Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPAR\u03b4","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53623-5","article-title":"Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes","volume":"15","author":"Alcalde-Herraiz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116416_bb0285","article-title":"Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes","volume":"15","author":"Li","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"Pt B","key":"10.1016\/j.intimp.2026.116416_bb0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biocel.2017.06.016","article-title":"How introns enhance gene expression","volume":"91","author":"Shaul","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116416_bb0295","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181510","article-title":"The association between peroxisome proliferator-activated receptor \u0394 rs3777744, rs3798343, and rs6922548 and coronary artery disease","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:12:35Z","timestamp":1777619555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S1567576926002602"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116416","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exenatide through PPAR\u03b4 improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116416"}}